Silvia Linari

2.5k total citations
75 papers, 1.7k citations indexed

About

Silvia Linari is a scholar working on Hematology, Genetics and Physiology. According to data from OpenAlex, Silvia Linari has authored 75 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Hematology, 20 papers in Genetics and 15 papers in Physiology. Recurrent topics in Silvia Linari's work include Hemophilia Treatment and Research (47 papers), Platelet Disorders and Treatments (27 papers) and Lysosomal Storage Disorders Research (11 papers). Silvia Linari is often cited by papers focused on Hemophilia Treatment and Research (47 papers), Platelet Disorders and Treatments (27 papers) and Lysosomal Storage Disorders Research (11 papers). Silvia Linari collaborates with scholars based in Italy, United States and Sweden. Silvia Linari's co-authors include Giancarlo Castaman, Massimo Morfini, Massimo Innocenti, Daniela Melchiorre, Christian Carulli, Stefan Lethagen, Alberto Tosetto, Claude Négrier, P. L. Turecek and Alok Srivastava and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Journal of Cellular Physiology.

In The Last Decade

Silvia Linari

70 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Silvia Linari Italy	22	1.3k	388	206	205	199	75	1.7k
Shirley D’Sa United Kingdom	25	1.4k 1.1×	758 2.0×	120 0.6×	469 2.3×	286 1.4×	122	2.4k
Haruhiko Ninomiya Japan	21	634 0.5×	321 0.8×	98 0.5×	164 0.8×	112 0.6×	82	1.3k
Sucha Nand United States	22	814 0.6×	339 0.9×	305 1.5×	452 2.2×	41 0.2×	72	1.6k
Brady L. Stein United States	25	985 0.8×	1.2k 3.2×	95 0.5×	808 3.9×	81 0.4×	105	2.1k
Y P M Goekoop-Ruiterman Netherlands	20	880 0.7×	485 1.3×	100 0.5×	159 0.8×	54 0.3×	30	2.6k
Koichi Amano Japan	28	431 0.3×	524 1.4×	163 0.8×	179 0.9×	150 0.8×	133	2.2k
Valeria Maria Pinto Italy	19	527 0.4×	648 1.7×	44 0.2×	115 0.6×	190 1.0×	57	1.0k
J.H.L.M. van Groenendael Netherlands	16	744 0.6×	406 1.0×	109 0.5×	106 0.5×	35 0.2×	22	2.1k
V. Aumann Germany	9	902 0.7×	400 1.0×	65 0.3×	110 0.5×	32 0.2×	30	1.7k
Alberto Spindler Argentina	18	351 0.3×	205 0.5×	101 0.5×	100 0.5×	48 0.2×	41	1.7k

Countries citing papers authored by Silvia Linari

Since Specialization

Citations

This map shows the geographic impact of Silvia Linari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvia Linari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvia Linari more than expected).

Fields of papers citing papers by Silvia Linari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvia Linari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvia Linari. The network helps show where Silvia Linari may publish in the future.

Co-authorship network of co-authors of Silvia Linari

This figure shows the co-authorship network connecting the top 25 collaborators of Silvia Linari. A scholar is included among the top collaborators of Silvia Linari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvia Linari. Silvia Linari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Eriksson, Daniel, et al.. (2024). Long-term efmoroctocog alfa prophylaxis improves perceived pain, mental, and physical health in patients with hemophilia A: post hoc analysis of phase III trials using patient-reported outcomes. Therapeutic Advances in Hematology. 15. 1574175677–1574175677.

Tran, Huyen, Sylvia von Mackensen, Aby Abraham, et al.. (2024). Concizumab prophylaxis in persons with hemophilia A or B with inhibitors: patient-reported outcome results from the phase 3 explorer7 study. Research and Practice in Thrombosis and Haemostasis. 8(4). 102476–102476. 6 indexed citations

Biasoli, Chiara, Erminia Baldacci, Antonio Coppola, et al.. (2022). Promoting physical activity in people with haemophilia: the MEMO (Movement for persons with haEMOphilia) expert consensus project. Nova Science Publishers (Nova Science Publishers, Inc.). 9 indexed citations

Minno, Giovanni Di, Antonio Coppola, Maurizio Margaglione, et al.. (2021). Predictors of inhibitor eradication by primary immune tolerance induction in severe haemophilia A with high responding inhibitors. Haemophilia. 28(1). 55–64. 10 indexed citations

Linari, Silvia, et al.. (2020). Concomitant Use of rFVIIa and Emicizumab in People with Hemophilia A with Inhibitors: Current Perspectives and Emerging Clinical Evidence. SHILAP Revista de lepidopterología. 1 indexed citations

Rocco, Maja Di, Alessio Di Fonzo, Antonio Barbato, et al.. (2020). Parkinson’s disease in Gaucher disease patients: what’s changing in the counseling and management of patients and their relatives?. Orphanet Journal of Rare Diseases. 15(1). 262–262. 5 indexed citations

Zanon, Ezio, Samantha Pasca, Elena Santagostino, et al.. (2019). Immune tolerance induction with moroctocog‐alpha (Refacto/Refacto AF) in a population of Italian haemophilia A patients with high‐titre inhibitors: Data from REF.IT Registry. Haemophilia. 25(6). 1003–1010. 2 indexed citations

Lunghi, Barbara, Francesco Bernardi, Nicola Martinelli, et al.. (2019). Functional polymorphisms in the LDLR and pharmacokinetics of Factor VIII concentrates. Journal of Thrombosis and Haemostasis. 17(8). 1288–1296. 16 indexed citations

Castaman, Giancarlo & Silvia Linari. (2016). Human von Willebrand factor/factor VIII concentrates in the management of pediatric patients with von Willebrand disease/hemophilia A. Therapeutics and Clinical Risk Management. Volume 12. 1029–1037. 9 indexed citations

10.

Linari, Silvia & Giancarlo Castaman. (2015). Hematological manifestations and complications of Gaucher disease. Expert Review of Hematology. 9(1). 51–58. 26 indexed citations

11.

Melchiorre, Daniela, Silvia Linari, Mirko Manetti, et al.. (2015). Clinical, instrumental, serological and histological findings suggest that hemophilia B may be less severe than hemophilia A. Haematologica. 101(2). 219–225. 50 indexed citations

12.

Linari, Silvia, Alessio Aghemo, Dario Bartolozzi, et al.. (2014). Interferon lambda 3 rs12979860 polymorphism in patients with haemophilia and HCV infection: a predictor of spontaneous viral clearance and sustained virological response. Thrombosis and Haemostasis. 111(6). 1067–1076. 5 indexed citations

13.

Rocco, Maja Di, Generoso Andria, Bruno Bembi, et al.. (2012). Minimal disease activity in Gaucher disease: Criteria for definition. Molecular Genetics and Metabolism. 107(3). 521–525. 4 indexed citations

14.

Carulli, Christian, Roberto Civinini, Claudia Martini, et al.. (2011). Viscosupplementation in haemophilic arthropathy: a long‐term follow‐up study. Haemophilia. 18(3). e210–4. 28 indexed citations

15.

Rocco, Maja Di, Fiorina Giona, Francesca Carubbi, et al.. (2008). A new severity score index for phenotypic classification and evaluation of responses to treatment in type I Gaucher disease. Haematologica. 93(8). 1211–1218. 50 indexed citations

16.

Turecek, P. L., Katalin Váradi, B. Keil, et al.. (2003). Factor VIII Inhibitor-Bypassing Agents Act by Inducing Thrombin Generation and Can Be Monitored by a Thrombin Generation Assay. Pathophysiology of Haemostasis and Thrombosis. 33(1). 16–22. 98 indexed citations

17.

Santagostino, Elena, M. Colombo, Maria Grazia Rumi, et al.. (2003). A 6-month versus a 12-month surveillance for hepatocellular carcinoma in 559 hemophiliacs infected with the hepatitis C virus. Blood. 102(1). 78–82. 79 indexed citations

18.

Frusconi, Sabrina, Ilaria Passerini, Francesca Girolami, et al.. (2002). Identification of seven novel mutations of F8C by DHPLC. Human Mutation. 20(3). 231–232. 11 indexed citations

19.

Vannucchi, Alessandro M., Alberto Bosi, P Pacini, et al.. (1998). Evaluation of breast tumour cell contamination in the bone marrow and leukapheresis collections by RT‐PCR for cytokeratin‐19 mRNA. British Journal of Haematology. 103(3). 610–617. 49 indexed citations

20.

Vannucchi, Alessandro M., Silvia Linari, Cristina Cellai, Mark J. Koury, & Francesco Paoletti. (1997). Constitutive and inducible expression of megakaryocyte‐specific genes in Friend erythroleukaemia cells. British Journal of Haematology. 99(3). 500–508. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact